GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biovica International AB (STU:9II) » Definitions » Total Long-Term Liabilities

Biovica International AB (STU:9II) Total Long-Term Liabilities : €0.33 Mil (As of Apr. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Biovica International AB Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Biovica International AB's Total Long-Term Liabilities for the quarter that ended in Apr. 2025 was €0.33 Mil.

Biovica International AB Total Long-Term Liabilities Historical Data

The historical data trend for Biovica International AB's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biovica International AB Total Long-Term Liabilities Chart

Biovica International AB Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.14 1.11 0.88 0.56 0.33

Biovica International AB Quarterly Data
Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.56 0.35 0.43 0.37 0.33

Biovica International AB Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Biovica International AB Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Biovica International AB's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Biovica International AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biovica International AB (STU:9II) » Definitions » Total Long-Term Liabilities
Comparable Companies
OSTO:NXTCL OSTO:ACOU OSTO:ATORX OSTO:SPAGO OSTO:EXPRS2 OSTO:ONCOZ OSTO:PILA XSAT:NIDHOG OSTO:NICA XSAT:CHOSA VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
BIOVIC B:Sweden
Address
Dag Hammarskjolds vag 54B, Uppsala Science Park, Uppsala, SWE, 752 37
Website
https://www.biovica.com
Biovica International AB is a biotech company. The company develops and commercializes blood-based diagnostic tests with biomarkers that improve the monitoring and evaluation of modern cancer treatments. The company promotes healthcare through collaboration with cancer institutes and pharmaceutical companies. DiviTum is manufactured by the company and sold as a kit consisting of a reaction plate with reagents that have been optimized for ELISA applications.

Biovica International AB Headlines

No Headlines